A.I. Virtanen Institute for Molecular Sciences - News

The Academy of Finland’s Research Council for Biosciences, Health and the Environment granted more than 5.2 million euros of funding to Academy Projects at the University of Eastern Finland.

The findings support the idea that even a modest reduction in the beta-amyloidogenic processing of APP may be a feasible strategy for the prevention of Alzheimer's disease.

The symposium is open to all scientists and clinicians who are interested in brain tumour research. It is free-of-charge for Ph.D. students enrolled in any doctoral programme at UEF, but there are only limited seats available.

The project examineses how mutations in the CACNA1C gene linked to psychiatric disorders and autism may affect microglia cells responsible for the brain’s immune defence.

The lecture topics range from radiation biology to forest planning, and from pharmaceutical policy and brain health to literature and education.

The research infrastructures of the University of Eastern Finland have been added to the national Research.fi portal, and they are also increasingly visible on the university’s own website.

Nicholas Downes of the A.I. Virtanen Institute for Molecular Sciences and Khai Pham Dinh of the Department of Chemistry secured a Finnish Foundations' Post Doc Pool grant.

The cell types associated with coronary artery disease were identified using the latest single cell technology.

A new study sheds light on the mechanisms of neural plasticity induced by the antidepressant fluoxetine.

The new protocol can be used, for example, to form a basis for multi-centre studies in the future.